F&FFinancial Insights

Financial Metrics

MDLN Medline Inc.
Range: 2016-01-01 to 2026-04-29
Chart Range:
% Change:

Financial Statements

Grouped by statement

Income Statement

Metrics: 6

Revenue

Q: 0 | A: 3

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2023-12-31 23231000000.0 USD 10-K 2026-02-25
Annual 2024-12-31 25507000000.0 +9.8% USD 10-K 2026-02-25
Annual 2025-12-31 28432000000.0 +11.5% USD 10-K 2026-02-25

Gross Profit

Q: 0 | A: 3

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2023-12-31 5885000000.0 USD 10-K 2026-02-25
Annual 2024-12-31 6976000000.0 +18.5% USD 10-K 2026-02-25
Annual 2025-12-31 7518000000.0 +7.8% USD 10-K 2026-02-25

Operating Income

Q: 0 | A: 3

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2023-12-31 1250000000.0 USD 10-K 2026-02-25
Annual 2024-12-31 2146000000.0 +71.7% USD 10-K 2026-02-25
Annual 2025-12-31 2212000000.0 +3.1% USD 10-K 2026-02-25

Net Income

Q: 0 | A: 3

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2023-12-31 234000000.0 USD 10-K 2026-02-25
Annual 2024-12-31 1163000000.0 +397.0% USD 10-K 2026-02-25
Annual 2025-12-31 -9000000.0 -100.8% USD 10-K 2026-02-25

EPS Basic

Q: 0 | A: 1

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2025-12-31 -0.01 USD/shares 10-K 2026-02-25

EPS Diluted

Q: 0 | A: 1

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Annual 2025-12-31 -0.01 USD/shares 10-K 2026-02-25

8-K Material Event Details

2 filings · 8 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

25 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value

All Transactions

Date Insider Title Type Security Shares Price Total Value Post-Tx Shares
2026-03-10 HEALY PATRICK J Other acquired transaction
J
Class A Common Stock 69,666 150,039
2026-03-10 HEALY PATRICK J Other acquired transaction
J
Class A Common Stock 507,844 1,208,159
2026-03-05 Golwas Douglas P Chief Commercial Officer Equity grant / award
A
Class A Common Stock 25,788 $0.00 $0 25,788
2026-02-11 CP Circle Holdings, L.P. Other disposed transaction
J · derivative
Common Units of Medline Holdings, LP 15,369,974 0
2026-02-11 CP Circle Holdings, L.P. Other disposed transaction
J
Class B Common Stock 15,369,974 0
2026-02-11 CP Circle Holdings, L.P. Other disposed transaction
J
Class A Common Stock 2,615 0
2026-01-16 TC Group VIII, L.L.C. Other disposed transaction
J
Class A Common Stock 94,348,666 0
2025-12-18 Hellman & Friedman Capital Partners X (Parallel), L.P. Exercise / conversion
C · derivative
Common Units 2,098,005 115,788,967
2025-12-18 Hellman & Friedman Capital Partners X (Parallel), L.P. Open-market sell
S · derivative
Common Units 9,028,455 $28.37 $256,125,531 117,886,972
2025-12-18 Hellman & Friedman Capital Partners X (Parallel), L.P. Other disposed transaction
J
Class B Common Stock 2,098,005 115,788,967
2025-12-18 Hellman & Friedman Capital Partners X (Parallel), L.P. Other disposed transaction
J
Class A Common Stock 2,098,005 19,310
2025-12-18 Hellman & Friedman Capital Partners X (Parallel), L.P. Exercise / conversion
C
Class A Common Stock 2,098,005 2,117,315
2025-12-18 Hellman & Friedman Capital Partners X (Parallel), L.P. Other disposed transaction
J
Class A Common Stock 313,116 8,955,577
2025-12-18 Hellman & Friedman Capital Partners X (Parallel), L.P. Other disposed transaction
J
Class A Common Stock 3,157,629 85,733,022
2025-12-18 Hellman & Friedman Capital Partners X (Parallel), L.P. Other disposed transaction
J
Class B Common Stock 9,028,455 117,886,972
2025-12-18 Hellman & Friedman Capital Partners X (Parallel), L.P. Open-market sell
S
Class A Common Stock 461,760 $28.37 $13,099,346 4,806,160
2025-12-18 Hellman & Friedman Capital Partners X (Parallel), L.P. Open-market sell
S
Class A Common Stock 547,305 $28.37 $15,526,112 9,268,693
2025-12-18 Hellman & Friedman Capital Partners X (Parallel), L.P. Open-market sell
S
Class A Common Stock 5,079,306 $28.37 $144,091,276 88,890,651
2025-12-16 Golwas Douglas P Chief Commercial Officer Equity grant / award
A · derivative
Incentive Units of Medline Holdings, LP 149,005 $4,124,458 149,005
2025-12-16 Golwas Douglas P Chief Commercial Officer Equity grant / award
A · derivative
Incentive Units of Medline Holdings, LP 157,800 $2,999,778 157,800
2025-12-16 Golwas Douglas P Chief Commercial Officer Equity grant / award
A · derivative
Incentive Units of Medline Holdings, LP 212,755 $3,240,259 212,755
2025-12-16 Golwas Douglas P Chief Commercial Officer Equity grant / award
A · derivative
Incentive Units of Medline Holdings, LP 463,211 $7,142,714 463,211
2025-12-16 Golwas Douglas P Chief Commercial Officer Equity grant / award
A · derivative
Incentive Units of Medline Holdings, LP 948,597 $14,627,366 948,597
2025-12-16 Golwas Douglas P Chief Commercial Officer Equity grant / award
A · derivative
Common Units of Medline Holdings, LP 465,864 465,864
2025-12-16 Golwas Douglas P Chief Commercial Officer Equity grant / award
A
Class B Common Stock 465,864 465,864

Regulatory Activity

Last 12 months to 2025-04-29
Insider Filings (Forms 3/4/5) — 12 months
9
Material Event Filings (8-K) — 12 months
2

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count
For informational purposes only — not guaranteed to be accurate or complete.